Haleon PLC Logo

Haleon PLC

A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-30 08:10
Earnings Release
Haleon 2025 Q3 Trading Statement
English 410.9 KB
2025-10-30 08:00
Report Publication Announcement
Haleon 2025 Q3 Trading Statement
English 14.7 KB
2025-10-10 13:45
Director's Dealing
Director/PDMR Shareholding
English 39.5 KB
2025-10-02 11:05
Board/Management Information
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director's Dealing
Director/PDMR Shareholding
English 115.8 KB
2025-09-24 16:00
Major Shareholding Notification
Holding(s) in Company
English 39.0 KB
2025-09-23 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.1 KB
2025-09-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Haleon PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea 048530
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea 389470
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden IRLAB
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea 086890
IVF HARTMANN Holding AG Logo
Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.
Switzerland VBSN
Japan Tissue Engineering Co., Ltd. Logo
Pioneers regenerative medicine with tissue products, CDMO services, and research models.
Japan 7774
Develops therapies for rare genetic diseases, CNS disorders, and regenerative medicine.
Japan 4552

Talk to a Data Expert

Have a question? We'll get back to you promptly.